These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 32864167)
21. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Fu MR; Chen CM; Haber J; Guth AA; Axelrod D Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528 [TBL] [Abstract][Full Text] [Related]
22. A novel, validated method to quantify breast cancer-related lymphedema (BCRL) following bilateral breast surgery. Miller CL; Specht MC; Horick N; Skolny MN; Jammallo LS; O'Toole J; Taghian AG Lymphology; 2013 Jun; 46(2):64-74. PubMed ID: 24354105 [TBL] [Abstract][Full Text] [Related]
23. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Farley CR; Irwin S; Adesoye T; Sun SX; DeSnyder SM; Lucci A; Shaitelman SF; Chang EI; Ueno NT; Woodward WA; Teshome M Ann Surg Oncol; 2022 Oct; 29(10):6370-6378. PubMed ID: 35854031 [TBL] [Abstract][Full Text] [Related]
24. Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran. Honarvar B; Sayar N; Tahmasebi S; Zakeri Z; Talei A; Rostami S; Khademi S; Sabzi Sarvestani A; Sekhavati E Asian Pac J Cancer Prev; 2016; 17(S3):81-6. PubMed ID: 27165213 [TBL] [Abstract][Full Text] [Related]
25. Features, Predictors, and Treatment of Breast Cancer-related Lymphedema. Zhang X; Oliveri JM; Paskett ED Curr Breast Cancer Rep; 2020 Dec; 12(4):244-254. PubMed ID: 34012502 [TBL] [Abstract][Full Text] [Related]
26. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174 [TBL] [Abstract][Full Text] [Related]
27. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema. Vicini F; Shah C; Whitworth P; Walker M; Shi J Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336 [No Abstract] [Full Text] [Related]
28. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions. Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599 [TBL] [Abstract][Full Text] [Related]
29. Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up. Invernizzi M; Corti C; Lopez G; Michelotti A; Despini L; Gambini D; Lorenzini D; Guerini-Rocco E; Maggi S; Noale M; Fusco N BMC Cancer; 2018 Sep; 18(1):935. PubMed ID: 30268112 [TBL] [Abstract][Full Text] [Related]
30. Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab. Invernizzi M; Michelotti A; Noale M; Lopez G; Runza L; Giroda M; Despini L; Blundo C; Maggi S; Gambini D; Fusco N J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30682851 [TBL] [Abstract][Full Text] [Related]
31. Identification Of A Higher Risk Lymphedema Phenotype And Associations With Cytokine Gene Polymorphisms. Miaskowski C; Conley YP; Cooper BA; Paul SM; Smoot BJ; Hammer MJ; Fu M; Levine JD J Pain Symptom Manage; 2024 May; 67(5):375-383.e3. PubMed ID: 38307372 [TBL] [Abstract][Full Text] [Related]
32. Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Stanton AW; Modi S; Mellor RH; Levick JR; Mortimer PS Lymphat Res Biol; 2009; 7(1):29-45. PubMed ID: 19302022 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions. Sayegh HE; Asdourian MS; Swaroop MN; Brunelle CL; Skolny MN; Salama L; Taghian AG Curr Breast Cancer Rep; 2017 Jun; 9(2):111-121. PubMed ID: 28894513 [TBL] [Abstract][Full Text] [Related]
35. The Development of Breast Cancer-Related Lymphedema After Mastectomy in a Rural Population. Clegg DJ; Whiteaker EN; Salomon BJ; Brooks AJ; Bell JL; Boukovalas S; Roberson PNE; Lloyd JM Am Surg; 2023 Aug; 89(8):3591-3593. PubMed ID: 36921062 [TBL] [Abstract][Full Text] [Related]
36. Physical activity level and age contribute to functioning problems in patients with breast cancer-related lymphedema: a multicentre cross-sectional study. De Vrieze T; Gebruers N; Nevelsteen I; Tjalma WAA; Thomis S; De Groef A; Dams L; Van der Gucht E; Devoogdt N Support Care Cancer; 2020 Dec; 28(12):5717-5731. PubMed ID: 32193692 [TBL] [Abstract][Full Text] [Related]
37. The Impact of L-Dex(®) Measurements in Assessing Breast Cancer-Related Lymphedema as Part of Routine Clinical Practice. Laidley A; Anglin B Front Oncol; 2016; 6():192. PubMed ID: 27656420 [TBL] [Abstract][Full Text] [Related]
38. Breast cancer-related lymphedema: women's experiences with an underestimated condition. Thomas-MacLean R; Miedema B; Tatemichi SR Can Fam Physician; 2005 Feb; 51(2):246-7. PubMed ID: 16926934 [TBL] [Abstract][Full Text] [Related]
39. Lymphedema in survivors of breast cancer. He L; Qu H; Wu Q; Song Y Oncol Lett; 2020 Mar; 19(3):2085-2096. PubMed ID: 32194706 [TBL] [Abstract][Full Text] [Related]
40. The Effect of Education on Knowledge Regarding Breast Cancer Related Lymphedema Risk Reduction and Prevention Among Nursing Personnel. Natarajan MK; S J N; Mohanraj J; Vishwanath U Cureus; 2023 Sep; 15(9):e45331. PubMed ID: 37849580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]